Sesderma allies with the Wanjing Aesthetic Medicine Group to boost the distribution of its products in China

Mediderma, the professional division of the Valencian company Laboratories Sesderma, promotes its international expansion plan and announces its entry into the Chinese market through a strategic distribution agreement with Wanjing Group, one of the main referents of the aesthetic medicine sector in China. With this operation, Mediderma adds its presence worldwide, with sales in Latin America, the USA, Europe, the Middle East, Africa and Asia-Pacific. Mediderma thus implies in the Chinese market in order to maintain a more direct commercial relationship with its customers and enhance its growth. China is a market with a lot of cosmetic and key demand in the Strategic Growth Plan of the Spanish Group. In this way, Mediderma signs an agreement with Wanjing Group for two years, renewables, with the aim of directly controlling the entire value chain between the company and the Chinese consumer. Sagun has underlined Gabriel Serrano, president and founder of Laboratories Mediderma and Sesderma, China represents one of the areas with the highest growth potential for the company. «Currently, China has 1.4 billion inhabitants, and Wanjing Group has a network of more than 45,000 professional aesthetic centers, which will allow Mediderma to significantly expand its presence in the Asian market,» said the company's owner. «It is a great opportunity to expand our presence and respond to the specific needs of Chinese skins, which require a unique approach in skin care products. With a solid strategy and effective products, we are sure that we can establish a relationship of trust with Chinese customers and be a reference brand in the market,» they say from the company. On the other hand, Sesderma is not new in the market of the Asian giant 2017. In 2023, Sesderma was the only Spanish dermocosmetic company that was among the 30 most important in the elaborated ranking of the 11 of 11 campaign, according to the data provided by Timor, which is the main online sales platform in China and that moves more than 60% of the total digital trade in the Asian giant. In addition, the laboratory opened a subsidiary in China in 2019. The business lines of the group founded by Dr. Gabriel Serrano are divided into the following: Sesderma, directly focused on the final consumer through pharmacies, parapharmacies and online sale; and Mediderma Professional Care, which manufactures, distributes and markets products and treatments for professional use, aimed exclusively at the aesthetic medical and dermatologist.